… Treatment Strategies for Cardiac Fibrosis Research to develop tools for diagnosing and treating … for drug delivery to treat cardiac … X. Drugs for treating myocardial fibrosis. Front Pharmacol. … prognostic biomarkers for coronary artery disease, unstable angina, …

… an aggressive goal of treating these patients to … the heart muscle. Treatment guidelines include administering aspirin … provider teams to consistently treat heart attack patients … provided for patients with coronary artery disease, specifically high-risk …

… for treating non-sleepy patients and consider focussing treatment for … planning a new clinical trial focused on people with … 60%, and the risk of coronary heart disease by 30%. “Three major … sleep apnoea: a multi-trial analysis”, by Ali Azarbarzin …

… REMBRANDT Phase 3 trial: The trial will utilize coronary … developing to overcome the limitations of current LDL-lowering treatments … -based, leading international pharmaceutical and diagnostics company. … 27 million with coronary heart disease and 19 million …

… guidelines for treating non-sleepy patients and consider focussing treatment for cardiovascular … are planning a new clinical trial focused on people with high … 60%, and the risk of coronary heart disease by 30%. Three major randomised …

… , such as coronary artery disease (CAD), arrhythmia(irregular … medications. More studies are needed to explore how factors like treatment … treating cancer. 9. Type 2 Diabetes  Type 2 diabetes develops … Food and Drug Administration (FDA) classifies curcuminoids …

… advancing treatment options for patients with Small-Vessel Coronary Artery Disease ( … , single-blind randomised trial (2:1 randomization) … Balloon (SCB) to Drug-Eluting Stents (Everolimus … in coronary interventions, treating arterial blockages without permanent …

… mission to revolutionise coronary artery disease (CAD) treatment and expands … , single-blind randomised trial (2:1 randomisation) … in coronary interventions, treating arterial blockages without … research and development of novel drug-delivery platforms …

… mission to revolutionize coronary artery disease (CAD) treatment and expands … , single-blind randomized trial (2:1 randomization) … in coronary interventions, treating arterial blockages without … coated balloon platform, developed with proprietary Nanoluté …

… mission to revolutionize coronary artery disease (CAD) treatment and expands … , single-blind randomized trial (2:1 randomization) … in coronary interventions, treating arterial blockages without … research and development of novel drug-delivery platforms …